Newmont at record highs: buy or wait?
Newmont (ASX: NEM) has delivered one of the standout performances on the ASX this year, surging approximately 135 per cent to trade near AUD $150 per share as gold prices soar to record highs near USD $4,300 per ounce. The world's largest gold miner is generating record free…
The Australian Securities Exchange (ASX) has become one of the most active and diverse financial marketplaces in the Asia-Pacific region, and among its many listed sectors, gambling-related companies occupy a unique and influential position.
These firms range from global gaming-technology providers to sports-betting operators and payment-service companies. Understanding how gambling stocks work on the ASX requires…
ASX Gold Stocks: Profits Surge After Fed Rate Cut
Gold surged past US$4,300 per ounce on Friday, testing the record highs reached in October, after the US Federal Reserve delivered its third rate cut of 2025. The 25 basis point reduction brought rates to 3.5-3.75 per cent, their lowest level in three years. For ASX…
Nickel Industries Gains Quota Approval: What’s Next for Investors?
Nickel Industries (ASX: NIC) finally has the green light investors have been waiting for. Indonesian authorities approved an increase to the company's 2025 ore sales quota from 9 million to 10.5 million wet metric tonnes, allowing sales to restart immediately. For a stock trading around AUD…
ANZ Group Holdings (ASX: ANZ) finds itself in an unusual position today. Former CEO Shayne Elliott has launched legal action against the bank, claiming it breached his departure agreement by stripping A$13.5 million in bonuses. Yet shares are trading around A$35.70, up roughly 1% on the day and near 52-week highs.
For investors, this creates a…
Prairie Lithium Secures Offtake Deal - A Buy at Current Levels?
Prairie Lithium (ASX: PL9) announced today that it has secured a binding offtake agreement with South Korea's Hydro Lithium. This locks in 100 per cent of production from its Phase 1 plant. Coming just two months after a deal with US-based Stardust Power, we…
Neurizon Therapeutics (ASX: NUZ) just hit a major milestone. The FDA has cleared its lead drug NUZ-001 to enter the HEALEY ALS Platform Trial at Massachusetts General Hospital, with patients now enrolling for this Phase 2/3 study in Q4 2025. This follows the FDA lifting its clinical hold back in October 2025. For investors, the…
Marmota (ASX: MEU) jumped around 50 per cent this week after reporting what management called "spectacular" gold results from its Greenewood project in South Australia's Gawler Craton. The standout grades include 109 g/t and 95 g/t gold from shallow depths, making these the best results in the region since Challenger was discovered back in 1995.…
Fenix Resources (ASX: FEX) surged 14% to around 49.5 cents after releasing an ambitious three-year production plan that targets a ramp-up from 2.4 million tonnes in FY25 to as much as 6 million tonnes by FY28. The plan centres on the company's transition from its maturing Iron Ridge and Shine mines to the larger-scale Weld…
Perseus Mining's Failed Bid: What's Next for ASX: PRU?
Perseus Mining (ASX: PRU) has withdrawn its A$2.1 billion takeover bid for Predictive Discovery. The move came after Robex Resources matched Perseus's offer before the December 10 deadline. Perseus had offered a 24.5 per cent premium, and Predictive's board called it a superior deal. However, Robex…
